Drug Costs
Concept
Vocabulary Service
Overview
subject area of
-
<p>Cost-Effectiveness Of Once-Daily Single-Inhaler Triple Therapy In COPD: The IMPACT Trial</p> Academic Article
-
<p>Economic impact of delaying initiation with multiple-inhaler maintenance triple therapy in Spanish patients with chronic obstructive pulmonary disease</p> Academic Article
-
<p>Impact of Single Combination Inhaler versus Multiple Inhalers to Deliver the Same Medications for Patients with Asthma or COPD: A Systematic Literature Review</p> Academic Article
-
A Critical Analysis of Studies of State Drug Reimbursement Policies: Research in Need of Discipline Academic Article
-
A Model for Assessing the Cost-Effectiveness of Atorvastatin and Simvastatin in Achieving Canadian Low-Density Lipoprotein Cholesterol Targets Academic Article
-
A Multinational Pharmacoeconomic Evaluation of Acute Major Depressive Disorder (MDD): a Comparison of Cost-Effectiveness Between Venlafaxine, SSRIs and TCAs Academic Article
-
A Randomized Trial Comparing Omeprazole, Ranitidine, Cisapride, or Placebo in Helicobacter pylori Negative, Primary Care Patients with Dyspepsia: The CADET-HN Study Academic Article
-
A SECOND LOOK AT PHARMACEUTICAL SPENDING AS DETERMINANTS OF HEALTH OUTCOMES IN CANADA Academic Article
-
A Time-Trend Economic Analysis of Cancer Drug Trials Academic Article
-
A pharmacoeconomic evaluation of two new products for the treatment of overactive bladder. Academic Article
-
A pilot study on cost-related medication nonadherence in Ontario. Academic Article
-
A population-based analysis of incentive payments to primary care physicians for the care of patients with complex disease Academic Article
-
A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma. Academic Article
-
A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 2 of 2): economic results Academic Article
-
A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients. Conference Paper
-
A reappraisal of generic bisphosphonates in osteoporosis Academic Article
-
A review and economic evaluation of bronchodilator delivery methods in hospitalized patients Academic Article
-
An economic evaluation of combination treatment with budesonide and formoterol in patients with mild-to-moderate persistent asthma Academic Article
-
Andexanet alfa for the treatment of hemorrhage Academic Article
-
Antifibrinolytics may be cost saving among recent recipients of combined acetylsalicylic acid and clopidogrel who undergo coronary artery bypass graft surgery. Academic Article
-
Antihypertensive treatment – navigating between cost, compliance and complications Academic Article
-
At-risk registers integrated into primary care to stop asthma crises in the UK (ARRISA-UK): study protocol for a pragmatic, cluster randomised trial with nested health economic and process evaluations Academic Article
-
Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data. Academic Article
-
Barriers and facilitators of thromboprophylaxis for medical-surgical intensive care unit patients: A multicenter survey Academic Article
-
Botulinum Toxin Type A and Acute Drug Costs in Migraine with Triptan Overuse Academic Article
-
COST-effectiveness of salmeterol/fluticasone propionate combination (Advair®) in uncontrolled asthma in Canada Academic Article
-
Calculating the Affordability of Antiretrovirals in St Lucia Academic Article
-
Canadian Economic Evaluation of Budesonide-Formoterol as Maintenance and Reliever Treatment in Patients with Moderate to Severe Asthma Academic Article
-
Canadian cost- utility analysis of intravenous immunoglobulin for acute childhood idiopathic thrombocytopenic purpura. Academic Article
-
Cancer Care Ontario's New Drug Funding Program: controlled introduction of expensive anticancer drugs. Academic Article
-
Chemotherapy waste reduction through shelf-life extension. Academic Article
-
Combination Therapy to Prevent Cardiovascular Disease Academic Article
-
Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges Academic Article
-
Cost Implications of the Use of Ramipril in High-Risk Patients Based on the Heart Outcomes Prevention Evaluation (HOPE) Study Academic Article
-
Cost effectiveness analysis of population-based serology screening and 13C-Urea breath test for Helicobacter pylori to prevent gastric cancer: A markov model Academic Article
-
Cost implications of the use of basal insulin glargine in people with early dysglycemia: The ORIGIN trial Academic Article
-
Cost prediction models for the comparison of two groups Academic Article
-
Cost-Effectiveness Analysis of a Randomized Trial Comparing Care Models for Chronic Kidney Disease Academic Article
-
Cost-Effectiveness of Dronedarone in Patients With Atrial Fibrillation in the ATHENA Trial Academic Article
-
Cost-Effectiveness of Pharmacomechanical Catheter-Directed Thrombolysis Versus Standard Anticoagulation in Patients With Proximal Deep Vein Thrombosis Academic Article
-
Cost-effectiveness analysis of secukinumab for the treatment of active psoriatic arthritis: a Canadian perspective Academic Article
-
Cost-effectiveness modelling of recombinant FSH versus urinary FSH in assisted reproduction techniques in the UK Academic Article
-
Cost-effectiveness of clopidogrel in acute coronary syndromes in Sweden: a long-term model based on the cure trial Academic Article
-
Costs of Remission and Recovery Using Family Therapy for Adolescent Anorexia Nervosa: A Descriptive Report Academic Article
-
Design of Effective Health Decision Support Systems: Towards Automating the Health Administrator's Decision Processes Academic Article
-
Direct and indirect costs incurred by Australian living kidney donors Academic Article
-
Direct and indirect costs of management of long‐term warfarin therapy in Canada Academic Article
-
Drug Reimbursement Policies in Canada—Need for Improved Access to Critical Therapies Academic Article
-
Earlier Initialization of Highly Active Antiretroviral Therapy Is Associated With Long-Term Survival and Is Cost-Effective Academic Article
-
Economic Evaluation of Bevacizumab for the First-Line Treatment of Newly Diagnosed Glioblastoma Multiforme Academic Article
-
Economic analysis of Neoral in de novo renal transplant patients in Canada. Academic Article
-
Economic analysis of epoetin alfa in critically ill trauma patients Academic Article
-
Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trial Academic Article
-
Economic issues in glycoprotein IIb/IIIa receptor therapy Academic Article
-
Economics, health-related quality of life, and cost-effectiveness methods for the TACTICS (Treat Angina with Aggrastat® [tirofiban] and Determine Cost of Therapy with Invasive or Conservative Strategy)–TIMI 18 trial Academic Article
-
Effect of a Proton Pump Inhibitor Deprescribing Guideline on Drug Usage and Costs in Long-Term Care Academic Article
-
Efficacy and Cost of Low-Molecular-Weight Heparin Compared with Standard Heparin for the Prevention of Deep Vein Thrombosis after Total Hip Arthroplasty Academic Article
-
Erectile dysfunction in spinal cord injury: a cost-utility analysis Academic Article
-
Erythropoietin in the management of patients with nonhematologic cancer receiving chemotherapy. Systemic Treatment Program Committee. Academic Article
-
Estimating the clinical cost of drug development for orphan versus non-orphan drugs Academic Article
-
Evaluating the impact of reference-based pricing. Academic Article
-
Evaluation of Subcutaneous Rituximab Administration on Canadian Systemic Therapy Suites Academic Article
-
Factor IX pharmacokinetics: differences between plasma-derived and recombinant products and the clinical and economic implications: a meeting report Conference Paper
-
Family Physician attitudes about prescribing using a drug formulary Academic Article
-
GP fundholding and prescribing in UK general practice: evidence from two rural, English Family Health Services Authorities. Academic Article
-
General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial Academic Article
-
Global access to affordable direct oral anticoagulants Academic Article
-
Glycoprotein IIb/IIIa Receptor Therapy in Percutaneous Coronary Intervention and Non???ST-Segment Elevation Acute Coronary Syndromes Academic Article
-
Haemophilia prophylaxis: how can we justify the costs? Academic Article
-
Healing an ailing pharmaceutical system: prescription for reform for United States and Canada Academic Article
-
Health care policy evaluation using longitudinal insurance claims data: An application of the Panel Tobit estimator Conference Paper
-
Health care utilisation and costs associated with different treatment protocols for newly diagnosed childhood acute lymphoblastic leukaemia: A population-based study in Ontario, Canada Academic Article
-
Health economic evaluation of rivaroxaban in the treatment of patients with chronic coronary artery disease or peripheral artery disease Academic Article
-
Health economics of gastroesophageal reflux disease. Academic Article
-
Highly Priced Gene Therapies: A Wake-Up Call for Early Price Regulation Academic Article
-
How do researchers determine the difference to be detected in superiority trials? Results of a survey from a panel of researchers Academic Article
-
Impact of Cardiac Implantable Electronic Device Infection Academic Article
-
Impact of a clinical pharmacist in a multidisciplinary intensive care unit Academic Article
-
Impact of a restrictive drug access program on the risk of cardiovascular encounters in children exposed to ADHD medications. Academic Article
-
Impact of antibiotic treatment duration on outcomes in older men with suspected urinary tract infection: Retrospective cohort study Academic Article
-
Impact of reference-based pricing of nitrates on the use and costs of anti-anginal drugs. Academic Article
-
Increased Eligibility for Treatment of Chronic Hepatitis C Infection with Shortened Duration of Therapy: Implications for Access to Care and Elimination Strategies in Canada Academic Article
-
Incremental costs of fragility fractures: a population-based matched -cohort study from Ontario, Canada Academic Article
-
Incremental healthcare utilisation and costs among new senior high-cost users in Ontario, Canada: a retrospective matched cohort study Academic Article
-
Intrapleural Dornase and Tissue Plasminogen Activator in pediatric empyema (DTPA): a study protocol for a randomized controlled trial Academic Article
-
Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians Academic Article
-
Management of HER2-positive breast cancer in Asia: consensus statement from the Asian Oncology Summit 2009 Academic Article
-
Management of venous thromboembolism in patients with cancer: role of dalteparin Academic Article
-
Medication use and its impact on high-cost health care users among older adults: protocol for the population-based matched cohort HiCOSTT study Academic Article
-
MedsCheck: an opportunity missed Academic Article
-
Meta-Analysis of Randomized Controlled Trials of Prophylactic Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor After Autologous and Allogeneic Stem Cell Transplantation Academic Article
-
Misdiagnosis of bipolar disorder as borderline personality disorder: clinical and economic consequences Academic Article
-
Modeling Tiered Pricing Frameworks: A Simulation Approach Academic Article
-
NCDs and the WHO Essential Medicines Lists: children need universal health coverage too Academic Article
-
Nonulcer dyspepsia and proton pump inhibitors Academic Article
-
Optimizing the use of prescription drugs in Canada through the Common Drug Review Academic Article
-
Oral steroids for the resolution of otitis media with effusion (OME) in children (OSTRICH): study protocol for a randomised controlled trial Academic Article
-
PHARMAC and treatment of bipolar depression--the limits of utilitarianism. Academic Article
-
Palbociclib in hormone receptor positive advanced breast cancer: A cost-utility analysis Academic Article
-
Patient characteristics and costs of severe sepsis and septic shock in Quebec Academic Article
-
Patients’ Willingness-to-Pay for an Alzheimer’s Disease Medication in Canada Academic Article
-
Pharmacokinetic implications of dosing emicizumab based on vial size: A simulation study Academic Article
-
Population-Based Study to Determine the Health System Costs of Using the 21-Gene Assay Academic Article
-
Prevention of catheter lumen occlusion with rT-PA versus heparin (Pre-CLOT): study protocol of a randomized trial [ISRCTN35253449] Academic Article
-
Projected impact of biosimilar substitution policies on drug use and costs in Ontario, Canada: a cross-sectional time series analysis Academic Article
-
Re: Cost-Effectiveness of Aspirin Chemoprevention for Barrett's Esophagus Academic Article
-
Reference-based pricing (RBP) of prescription drugs. Academic Article
-
Resistance to antibiotics: administrative response to the challenge. Academic Article
-
Resource Use and costs of End-Of-Life/Palliative Care: Ontario Adult Cancer Patients Dying during 2002 and 2003 Academic Article
-
Resource use and costs of treating acute cough/lower respiratory tract infections in 13 European countries: results and challenges Academic Article
-
Resource utilization and costs in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme Academic Article
-
Sample size and power issues in estimating incremental cost-effectiveness ratios from clinical trials data Academic Article
-
Screening for Osteoporosis in Postmenopausal Women With Breast Cancer Receiving Aromatase Inhibitors: Less Is More? Academic Article
-
Socioeconomic factors and use of secondary preventive therapies for cardiovascular diseases in South Asia: The PURE study Academic Article
-
Stakeholders’ feedback on the proposed recommendations for updating the patented medicine prices review board (pmprb) budget impact analysis guidelines Academic Article
-
Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia Academic Article
-
The Cost of Clopidogrel Use in Atrial Fibrillation in the ACTIVE-A Trial Academic Article
-
The Diagnosis of Urinary Tract Infection in Young Children (DUTY) Study Clinical Rule: Economic Evaluation Academic Article
-
The Effect of ICU Sedation Guidelines and Pharmacist Interventions on Clinical Outcomes and Drug Cost Academic Article
-
The German method for setting ceiling prices for drugs: in some cases less data are required Academic Article
-
The Impact of Tiered-Pricing Framework on Generic Entry in Canada Academic Article
-
The Role of Benzodiazepines in the Treatment of Insomnia Academic Article
-
The burden of illness of osteoporosis in Canada Academic Article
-
The cost burden of clinically significant esophageal anastomotic leaks—a steep price to pay Academic Article
-
The effect of patented drug price on the share of new medicines across OECD countries Academic Article
-
The effects of drug subsidies on out-of-pocket prescription drug expenditures by seniors: regional evidence from Canada Academic Article
-
The impact of recombinant human erythropoietin on medical care costs for hemodialysis patients in Canada Academic Article
-
The need to test the theories behind the Polypill: rationale behind the Indian Polycap Study Academic Article
-
The unintended (and costly) effects due to the introduction of an unrestricted reimbursement policy for atypical antipsychotic medications in a Canadian public prescription drug program: 1996/97 to 2005/06. Academic Article
-
Use of Antidepressants Among Elderly Subjects: Trends and Contributing Factors Academic Article
-
Use, costs, and predictors of psychiatric healthcare services following an autism spectrum diagnosis: Population-based cohort study Academic Article
-
Using Value-of-Information Methods when the Disease Is Rare and the Treatment Is Expensive—The Example of Hemophilia A Academic Article
-
Valuing Outcomes in Health Care Academic Article
-
What Is the Economic Value of Digoxin Therapy in Congestive Heart Failure Patients? Results From the DIG Trial Academic Article
-
When are Pharmaceuticals Priced Fairly? An Alternative Risk-Sharing Model for Pharmaceutical Pricing Academic Article